174 related articles for article (PubMed ID: 18251941)
1. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
[TBL] [Abstract][Full Text] [Related]
2. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas.
Weber A; Hengge UR; Stricker I; Tischoff I; Markwart A; Anhalt K; Dietz A; Wittekind C; Tannapfel A
Hum Pathol; 2007 Feb; 38(2):228-38. PubMed ID: 17020778
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray studies in bladder cancer.
Hartmann A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
6. Is gene expression profiling of head and neck cancers ready for the clinic?
Ziober AF; D'Alessandro L; Ziober BL
Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
Hussein MR; Cullen K
Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
[TBL] [Abstract][Full Text] [Related]
8. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma.
Freier K; Knoepfle K; Flechtenmacher C; Pungs S; Devens F; Toedt G; Hofele C; Joos S; Lichter P; Radlwimmer B
Genes Chromosomes Cancer; 2010 Jan; 49(1):9-16. PubMed ID: 19787784
[TBL] [Abstract][Full Text] [Related]
9. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarrays: a current medical research tool.
Shergill IS; Shergill NK; Arya M; Patel HR
Curr Med Res Opin; 2004 May; 20(5):707-12. PubMed ID: 15140337
[TBL] [Abstract][Full Text] [Related]
11. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.
Tzankov A; Went P; Zimpfer A; Dirnhofer S
Exp Gerontol; 2005; 40(8-9):737-44. PubMed ID: 16125349
[TBL] [Abstract][Full Text] [Related]
14. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
15. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarkers in head and neck cancer.
Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5005-6. PubMed ID: 16951212
[No Abstract] [Full Text] [Related]
17. [Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].
Jacquemier J; Ginestier C; Charafe-Jauffret E; Bertucci F; Bege T; Geneix J; Birnbaum D
Ann Pathol; 2003 Dec; 23(6):623-32. PubMed ID: 15094604
[TBL] [Abstract][Full Text] [Related]
18. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma.
Colombo J; Fachel AA; De Freitas Calmon M; Cury PM; Fukuyama EE; Tajara EH; Cordeiro JA; Verjovski-Almeida S; Reis EM; Rahal P
Oncol Rep; 2009 Mar; 21(3):649-63. PubMed ID: 19212623
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarrays: applications in genomic research.
Watanabe A; Cornelison R; Hostetter G
Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
